Skip to main content

IGM Biosciences, Inc.

IGMSDelisted Aug 14, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001496323

IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.

Q4 2023 vs. Q3 2023

How the institutions holding IGM Biosciences, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of IGMS: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders7972−7
Shares22.3M21.9M−407.4K (−1.8%)
Value$186.3M$182.1M−$4.25M (−2.3%)

New holders (17)

Institutions that held IGM Biosciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to IGMS in Q4 2023
InstitutionSharesValue% of portfolio
Adage Capital Partners GP, L.L.C.400,000$3.32M0.01%
Exome Asset Management LLC135,596$1.13M1.11%
Prudential Financial Inc65,870$547.4K0.00%
Pennant Investors, LP64,900$539.3K0.17%
Jane Street Group, LLC35,635$296.1K0.00%
Panagora Asset Management Inc30,273$251.6K0.00%
Susquehanna Portfolio Strategies, LLC30,209$251.0K0.00%
Susquehanna International Group, LLP13,656$113.5K0.00%
Amundi9,196$107.1K0.00%
Brevan Howard Capital Management LP11,877$98.7K0.01%
Deutsche Bank AG11,702$97.2K0.00%
Acadian Asset Management LLC8,367$69.0K0.00%
Simplex Trading, LLC1,810$15.0K0.00%
Comerica Bank617$5.13K0.00%
Northwestern Mutual Wealth Management Co500$4.16K0.00%
Farther Finance Advisors, LLC9$750.00%
The PNC Financial Services Group, Inc.7$580.00%

Sold out (24)

Institutions that held IGM Biosciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.